Showing papers by "Dennis Deapen published in 2012"

Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult

Abstract: BACKGROUND: The objective of this study was to explore the psychosocial impact of cancer on newly diagnosed adolescent and young adult (AYA) cancer patients. METHODS: This was a population-based, multicenter study of 523 newly diagnosed AYA survivors (ages 15-39 years) of germ cell cancer (n ¼ 204), non-Hodgkin lymphoma (n ¼ 131), Hodgkin lymphoma (n ¼ 142), acute lymphocytic leukemia (n ¼ 21), or sarcoma (n ¼ 25) from 7 National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) registries. Age at diagnosis was categorized into 3 groups (ages 15-20 years, 21-29 years, and 30-39 years). RESULTS: Respondents (43% response rate), on average (� standard deviation), were aged 29 ¼ 6.7 years, and most patients (80.1%) were not receiving treatment at the time the completed the survey. With modest differences between the age groups, the most prevalent areas of life impacted in a negative way were financial, body image, control over life, work plans, relationship with spouse/significant other, and plans for having children. Endorsement of positive life impact items also was evident across the 3 age groups, particularly with regard to relationships, future plans/goals, and health competence. CONCLUSIONS: The current results indicated that there will be future need for interventions targeting financial assistance, body image issues, relationships, and helping AYAs to attain their education objectives. Cancer 2012;118:5155–62. V C 2012 American Cancer Society.

Invasive breast cancer incidence trends by detailed race/ethnicity and age

Abstract: Racial/ethnic disparities in breast cancer incidence may contain important evidence for understanding and control of the disease. Monitoring the incidence trends of breast cancer by race/ethnicity allows identification of high risk groups and development of targeted prevention programs. Using population-based cancer registry data from the Los Angeles Cancer Surveillance Program, we examined the invasive female breast cancer incidence trends among the diverse racial/ethnic populations in Los Angeles County, California, from 1972 to 2007. Age-adjusted incidence rates (AAIRs) and age-specific incidence rates (ASIRs) were calculated and examined respectively for non-Hispanic (NH) white, black, Hispanic, Chinese, Filipina, Japanese and Korean women by calendar year and time period. Rising trends of AAIRs were found in all racial/ethnic groups during the 1980s and 1990s. The breast cancer risk increased more substantially in Japanese and Filipinas than in Chinese and Koreans. During 2000-2007, the trends of AAIRs declined significantly among NH white women and slightly in blacks, remained unchanged for Hispanics and continued to rise significantly among all Asian subgroups. The patterns of ASIRs by race/ethnicity changed dramatically over time. By 2000-2007, younger Hispanic women had the lowest breast cancer risk, replacing the Chinese and Koreans who formerly had the lowest risk. Rapidly increasing breast cancer incidence trends among Asian-Americans underline the importance of behavioral and lifestyle changes as a result of acculturation on the development of the disease. The unique trends of breast cancer incidence by race/ethnicity suggest the need for targeted breast cancer control programs for different racial/ethnic populations.

Lung cancer risk among construction workers in California, 1988–2007

Abstract: Background Although lung cancer risks can vary by race/ethnicity and by construction occupation, these risks have not been examined extensively. Methods This study analyzed 110,937 lung cancer cases identified from the California Cancer Registry between 1988 and 2007. Mean age at diagnosis, proportion diagnosed at an advanced stage, and proportion with 3-year survival were calculated for lung cancer cases employed in the construction industry. Case–control methodology was also used to assess the risk of lung cancer. Morbidity odds ratios (MORs) were estimated by conditional logistic regression. Results Construction workers were found to have a significantly elevated risk for all lung cancer combined (MOR = 1.57) and for each lung cancer histologic subtype examined. All construction occupations, except managers/engineers and supervisors, had a significantly elevated risk for all lung cancer combined. Roofers and welders had the highest risks for total lung cancer and for each of the histologic subtypes. Construction workers in each of the four race/ethnicity groups also had significantly increased lung cancer risks. Compared to non-construction workers, construction workers were diagnosed at an earlier age, at a more advanced stage, and had significantly lower 3-year survival, though differences were modest. Conclusion These findings justify additional reductions in carcinogenic exposures in construction, and increased support for smoking cessation programs at construction sites. Am. J. Ind. Med. 55:412–422, 2012. © 2012 Wiley Periodicals, Inc.

Leukemia among male construction workers in California, 1988-2007.

Abstract: A total of 18 708 male cases of leukemia from the California Cancer Registry, including 1703 cases usually employed in construction, were each matched with up to five controls from the same source who were diagnosed with cancers not thought to be related to exposures common in construction. Compared to other workers, construction workers were found to have a significantly elevated risk for all leukemia combined (morbidity odds ratio [MOR] = 1.14, 95% confidence interval [CI] = 1.08, 1.20), acute lymphocytic leukemia (ALL) (MOR = 1.30, 95% CI = 1.07, 1.58), acute myeloid leukemia (AML) (MOR = 1.15, 95% CI = 1.03, 1.27) and chronic myeloid leukemia (CML) (MOR = 1.25, 95% CI = 1.09, 1.44). Among the different construction occupations, the highest MOR for all leukemia was among carpet installers (MOR = 1.99, 95% CI = 1.16, 3.44), followed by plumbers (MOR = 1.28, 95% CI = 1.03, 1.59) and laborers (MOR = 1.26, 95% CI = 1.12, 1.42). Other associations were limited to specific construction occupations, l...

Abstract 3590: Use of four biomarkers to evaluate survival disparity between black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer

Abstract: Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Purpose: To evaluate the extent to which the black-white disparity in mortality following breast cancer diagnosis is explained by the expression status of four biomarkers - estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and p53 protein. Methods: The four biomarkers were assessed in paraffin-embedded breast tumor tissue for 1204 (523 black, 681 white) women, ages 35-64 years at diagnosis, who participated in the Women's CARE Study, a population-based case-control study of newly incident breast cancer, and who accrued a median of 10 years follow-up. The impact of these biomarkers on black-white disparity in breast cancer-specific and all-cause mortality was determined by fitting multivariable Cox proportional hazards regression models. Results: The black-white disparity in breast cancer-specific mortality was 54% in an age- and study site-adjusted model (relative risk [RR], 1.54; 95% confidence interval [CI], 1.21 to 1.97); it declined to a 36% greater risk for black women than white women after additionally controlling the status of the four markers (RR, 1.36; 95% CI, 1.06 to 1.75). Similar results were observed for all cause-mortality. Separate analyses for triple negative (ER-/PR-/HER2-) and luminal A (ER+ and/or PR+ plus HER2-) tumors showed that the black-white differences in mortality were predominately observed for older (50-64 years) women with luminal A tumors (breast cancer-specific RR, 2.07; 95% CI, 1.16 to 3.70; all-cause RR, 2.21; 95% CI, 1.40 to 3.47). For luminal A tumors, the greater mortality risk for older black women was attenuated after adjustment for stage, comorbidities, and education, and was most evident for all-cause mortality. Conclusions: Black-white differences in mortality following breast cancer diagnosis vary by tumor biomarker subtypes. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3590. doi:1538-7445.AM2012-3590